You searched for "occlusion"

1306 results found

Non-infectious Uveitis: Well Known, Weird and Wonderful meets You, Me and the Balloons

Installation view from Manchester International Festival 2023 exhibition Yayoi Kusama: You, Me and the Balloons at Aviva Studios. Images © David Levene. On an uncharacteristically salubrious 5 July 2023, the date of the 75th Anniversary of the UK’s NHS, a...

Can 3D facial imaging improve patient management in disfiguring eye disease?

Fight for Sight is the leading UK charity funder of eye research. Since the 2013 Sight Loss and Vision Priority Setting Partnership we have encouraged our researchers to work on priorities jointly identified by people affected by sight loss and...

Roll up! Roll up! Circus Starr’s inclusive show returns for one day only!

Circus Starr are excited to be back in Edinburgh with another inclusive circus inspired show!

Introducing Danny Laycock, talent solutions specialist for the ophthalmology sector with a truly global reach

Is your company changing the future of Ophthalmics? We’re collating a list of the top companies to watch in the space for 2024.

What's trending Oct/Nov 2019

#probeyeotic #eyeballbugs #microbiome The human microbiome usually conjures up images of the gastrointestinal tract and yoghurt containing good bacteria. However, research suggests that the ocular mucosa is home to a unique microbe collection, with important immunological functional properties [1]. This...

Squamous metaplasia of conjunctival epithelial cells with soft contact lens wear versus non-lens wearers

Conjunctiva is composed of non-squamous epithelial cells interspersed with goblet cells, which is a secretory epithelium. Squamous metaplasia is a transformation to non-secretory epithelium, ‘keratinised’ and enlargement of the conjunctival non-goblet cells and relatively shrunken nuclei are seen on impression...

Introducing BEAMS: A new national society for medical retina specialists

The specialty of medical retina is evolving. Initially, limited to pattern recognition and in later times, laser treatment, the past 20 years has seen an explosion of intravitreal therapies and a very rich pipeline resulting in sight-saving outcomes and hope...

Oct/Nov 2014 Quiz

History 12-year-old cattle herder in Bangladesh. Loss of vision right eye – over 2/12 to no perception of light (NPL). B-scan showed choroidal thickening. Suspected to be choroidal ‘tumour’. Enucleated. Figure 1. Figure 2. Figure 3. Figure 4. Figure 5....

Breakthroughs in the genetics of angle-closure glaucoma

Angle closure glaucoma (ACG) is not widely known to be a familial condition, yet the recent explosion of genetic data and large scale genome wide investigations have confirmed at least 13 genetic loci associated with ACG [1], and provided some...

New solutions in the prevention and treatment of Acanthamoeba keratitis

The global increase in Acanthamoeba keratitis infections has emphasised the inefficiencies of current treatment and preventative methods, here researchers from the West of Scotland detail a promising new series of compounds that may stem the tide. News headlines detailing horror...

GOSH (Great Ormond Street Hospital) Paediatric Ophthalmology Post-Graduate meeting - The Visiting Professors Day

Course Director: Prof Chris Lloyd, Consultant Ophthalmologist and Clinical Lead, Dept Ophthalmology, GOSH Event overview: The Visiting Professor's Day is a well-established GOSH Ophthalmology Unit tradition (dormant during the pandemic). It is all day postgraduate educational event aimed at those working with children with ophthalmic disorders including (but not exclusive to) Ophthalmologists, Orthoptists, Optometrists, Vision Scientists and academics. It will feature presentations from the GOSH ophthalmic and vision science team as well as talks from excellent external speakers including prominent "Visiting Professors" including Susmito Biswas (Cystinosis and the eye) Jane Ashworth (Advances in the ophthalmic management of the Mucopolysccharidoses) and Patrick Watts (Ophthalmic features of NAI; new RCOphth guidance).

Hanson Wade: Dry AMD and Geographic Atrophy Therapeutics Summit 2025

Welcome to the 6th Dry AMD and Geographic Atrophy Therapeutics SummitTransformative Therapies for Dry, Intermediate & Late-Stage AMDWith late-phase trials advancing, novel mechanisms emerging, and global regulatory expectations evolving, the dry AMD and GA field is accelerating exponentially. Returning digitally...